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Abstract
Most postoperative surgical patients routinely receive supplemental oxygen therapy to prevent the potential
development of hypoxemia due to incomplete lung re-expansion, reduced chest wall, and diaphragmatic activity
caused by surgical site pain, consequences of hemodynamic impairment, and residual effects of anesthetic drugs
(most notably residual neuromuscular blockade), which may result in atelectasis, ventilation–perfusion mismatch,
alveolar hypoventilation, and impaired upper airway patency. Additionally, the World Health Organization guidelines
for reducing surgical site infection have recommended the perioperative administration of high-dose oxygen,
including during the immediate postoperative period. However, supplemental oxygen and hyperoxemia also have
harmful effects on the respiratory and cardiovascular systems, with several clinical studies having reported an
association between high perioperative oxygen administration and worse clinical outcomes. Recently, the increased
availability of new and short-acting anesthetic drugs, comprehensive pharmacological knowledge, postoperative
multimodal analgesia, and new minimally invasive surgery options could result in lower incidences of postoperative
hypoxemia. Moreover, recommendations promoting high oxygen administration to prevent surgical site infections
have been challenged, considering the lack of scientific investigations, and have not been widely accepted. Given
the potential harmful effects of hyperoxemia, routine postoperative oxygen administration might not be
recommended. Recent clinical studies have indicated that a conservative approach to oxygen therapy, where
oxygen administration is titrated to achieve slightly lower oxygen levels than usual, could be safely implemented
and decrease acutely ill patients’ susceptibility to hyperoxemia. Based on current evidence, appropriate monitoring,
including peripheral oxygen saturation, and oxygen titration should be required during postoperative oxygen
administration to avoid both hypoxemia and hyperoxemia. Future trials should therefore focus on determining the
optimal oxygen target during postoperative care.
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Background
Most postoperative surgical patients routinely receive
supplemental oxygen therapy to prevent hypoxemia, one
of the most frequent and important postoperative re-
spiratory complications. Moreover, while routine supple-
mental oxygen administration is not recommended for
non-hypoxemic patients with several acute conditions,
such as acute coronary syndrome [1, 2] and stroke [3, 4],
the postoperative period is one of the few circumstances
where high-dose oxygen therapy has been recommended
to reduce surgical site infections (SSIs) [5]. However,
such recommendations remain controversial and have
not been widely accepted in actual clinical practice [6–
8]. The present paper therefore reviews the rationale,
clinical significance, and controversies regarding postop-
erative oxygen therapy and re-evaluates the optimal use
of postoperative oxygen.
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Rationale for postoperative oxygen
administration
Postoperative patients are susceptible to hypoxemia because
of incomplete lung re-expansion, reduced chest wall, and
diaphragmatic activity caused by surgical injury and pain,
consequences of hemodynamic impairment, and residual ef-
fects of anesthetic drugs (most notably residual neuromuscu-
lar blockade) [9, 10], which may result in atelectasis,
ventilation–perfusion mismatch, alveolar hypoventilation,
and impaired upper airway patency among others (Table 1)
[11]. Postoperative shivering may also increase oxygen con-
sumption, thereby increasing the risk of hypoxemia [12]. Ac-
cordingly, prolonged hypoxemia may promote serious
consequences, including arrhythmias [13, 14], myocardial is-
chemia [15], and cognitive dysfunction [16].
Reports have also shown that systemic hypoxemia im-
pairs wound healing and suppresses certain aspects of
the immune response, which can increase the risk of
wound infections. Oxidative killing by neutrophils was
impaired at low oxygen tensions often found in wounds
[17]. Evidence therefore suggests that postoperative hyp-
oxemia carries a significant risk and should be carefully
avoided and immediately corrected. Accordingly, sup-
plemental oxygen administration could increase oxy-
gen tensions in the arterial blood, which might
provide a safety buffer and prevent hypoxemic events
at the cellular level.
Possible harmful effects of postoperative
hyperoxemic oxygen therapy
Oxygen has also been known to promote harmful
effects. Indeed, hyperoxemia and excessive oxygen ad-
ministration have a number of respiratory and cardiovas-
cular effects. The lungs are particularly vulnerable to
damage caused by prolonged exposure to high oxygen
levels. Accordingly, oxygen breathing has been found to
induce absorption atelectasis [18], while high fraction of
inspired oxygen (FIO2) can impede minute ventilation in
spontaneously breathing subjects, worsen ventilation–
perfusion matching by countering hypoxic pulmonary vaso-
constriction, and shift the carbon dioxide dissociation curve
to the right (Haldane effect) [19]. Another potentially harm-
ful consequence of administering unnecessarily high oxygen
concentrations is impaired detection of hypoventilation via
pulse oximetry. Supplemental oxygen in patients with spon-
taneous ventilation has been found to potentially promote
delayed recognition of deteriorating lung function in the
post-anesthesia care unit (PACU) [20].
Studies have shown that hyperoxemia reduces cardiac
output by approximately 10% and increases systemic
vascular resistance by 11–12% in both healthy volunteers
and patients with coronary artery disease, while patients
with heart failure exhibited a 15% decrease in cardiac
output and a 25% increase in systemic vascular resist-
ance [21]. Moreover, among patients undergoing elective
coronary angiography, those who received 100% oxygen
breathing had 20% lower coronary blood flow velocity
and 23% higher coronary resistance relative to those
who breathed room air [22].
Thus, some controversy exists regarding “routine” sup-
plemental oxygen administration following surgery.
However, the clinical significance of such potentially
harmful effects during the postoperative period has
remained uncertain [23].
Prevention of postoperative hypoxemia
Hypoxemia has remained one of the most frequent and
important postoperative respiratory complications. Ac-
cordingly, 35% of patients who underwent elective surgery
under general anesthesia developed hypoxemia [peripheral
oxygen saturation (SpO2) ≤ 90%] during postoperative
transfer, with 12% developing severe hypoxemia (SpO2 ≤
85%) [24]. An observational study by Sun et al., who ana-
lyzed oxygen saturation recorded at 1-min intervals for up
to 48 h after the surgery in 833 patients undergoing non-
cardiac surgery, found that 21% and 8% of the patients
had SpO2 levels of < 90% for longer than 10 and 20 min
per hour, respectively [25]. In addition, 37% of patients ex-
perienced at least one episode where SpO2 was < 90% for
an hour or more. Thus, postoperative hypoxemia is
relatively common and prolonged.
Several studies have shown that supplemental postop-
erative oxygen may prevent hypoxemia. Accordingly,
one study showed that although 19% of patients who
were transferred without oxygen experienced initial oxy-
gen desaturation (SpO2 < 90%) upon arrival at the
PACU, only 0.8% of those with oxygen supplementation
experienced the same [26]. Similar findings had also
been reported by Maity et al. [27] who showed that 28%
of patients who did not receive oxygen developed hypo-
xemia during the transfer from the operation theater to
the recovery room, whereas none of those who received
supplemental oxygen developed early postoperative
Table 1 Possible mechanisms of postoperative hypoxemia
Mechanism Factors involved
Atelectasis Direct compression of the lungs during
operation, Incomplete lung re-expansion,
Reduced chest wall and diaphragmatic
movement due to surgical injury or pain
Alveolar hypoventilation Depressed level of consciousness due to
residual effect of anesthetic drugs,
Postoperative opioids
Impaired upper
airway patency
Residual effect of neuromuscular blocking
agents, opioids, volatile anesthetics, or
other agents with sedative properties,
Airway tissue edema
Increased oxygen
consumption
Shivering, Fever, Systemic inflammatory
response
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hypoxemia. Therefore, routine oxygen administration
during the immediate postoperative period could pro-
vide a margin of safety against hypoxemia and has been
widely advocated for many years.
Although early studies have reported high incidences
of postoperative hypoxemia (as high as 55%) [28], inci-
dences have decreased to around 20% by the mid-2010s
[25–27, 29]. Such a decrease might have been related to
the increased availability of new and short-acting
anesthetic drugs [30, 31], comprehensive pharmaco-
logical knowledge, and multimodal analgesia techniques
for maximizing postoperative pain relief while minimiz-
ing side effects, and new minimally invasive surgery op-
tions. Thus, routine supplemental oxygen administration
to prevent hypoxemia might not be necessary in most
postoperative patients in recent years. In fact, a before-
and-after comparison study showed that the shift from
routine postoperative supplemental oxygen administra-
tion to titrated postoperative oxygen administration to
maintain SpO2 levels at 90% or higher could increase the
number of patients not needing supplemental oxygen
therapy [32].
Prevention of surgical site infection
In 2016, the World Health Organization (WHO) pub-
lished recommendations for reducing SSIs. The panel
performed a systematic review that compared the effects
of perioperative administration of high FIO2 (80%) and
standard FIO2 (30–35%) for the prevention of SSIs. Al-
though their results showed that high FIO2 had no over-
all significant benefit on preventing SSI [odds ratio (OR)
0.84; 95% confidence interval (CI) 0.66–1.06], a sub-
group analysis of trials where patients received oxygen
therapy through a tracheal tube showed that increased
perioperative FIO2 promoted a better reduction in SSI
compared to standard perioperative FIO2 (OR 0.72; 95%
CI 0.55–0.94) [33]. Based on the aforementioned evi-
dence, the WHO recommended that adult patients
undergoing general anesthesia with endotracheal intub-
ation for surgical procedures should receive 80% FIO2
intraoperatively and, if feasible, for 2–6 h immediately
after surgery. However, this has generated considerable
controversy, especially regarding trial selection, statistical
analysis [7, 34], and insufficient analysis of potentially
negative systemic effects of high oxygen administration
[35]. Additionally, one study included in the systematic
review, which found that liberal oxygen use reduced the
risk of infection after surgery, was retracted due to dis-
puted credibility [36]. In their 2018 update, the WHO
re-assessed the evidence, excluding questionable studies
and including three new randomized controlled trials
(RCTs) [37, 38]. Although the updated evidence showed
that high FIO2 had weaker benefits and the new guide-
lines downgraded the strength of the recommendation
from strong to conditional, the general recommendation
to ventilate intubated surgical patients with an FIO2 of
0.8 was retained [5].
Nonetheless, the new recommendation has still been
challenged [8, 39]. A recent large RCT including 717
patients undergoing abdominal surgery failed to identify
any beneficial effect of high perioperative FIO2 on SSI
[40]. Two recent studies, one being a retrospective ana-
lysis on administrative data from almost 74,000 patients
undergoing non-cardiothoracic surgery [41] and the
other being a prospective intervention study with more
than 5700 patients undergoing intestinal surgery [42],
had also generated controversy. Accordingly, both stud-
ies found that high FIO2 had no benefit on wound com-
plications, with the retrospective study even finding a
dose-dependent increase in frequency of pulmonary
complications with high FIO2 [41]. Additionally, follow-
up studies of the PROXI trial [43], one of the largest
RCTs with the lowest possible risk of bias and arguably
the best designed trial conducted to date, found that
80% oxygen administration during the perioperative
period was associated with significantly increased long-
term mortality [44], shorter time to cancer recurrence or
death [45], and long-term risk of myocardial infarction
[46]. Thus, concerns regarding high FIO2 and mainten-
ance of hyperoxemia during and after surgery have still
persisted [8, 23, 39].
Re-evaluation of postoperative oxygen therapy
Based on the aforementioned discrepancy, routine post-
operative oxygen administration and the recommenda-
tion of high perioperative FIO2 to reduce SSI need to be
reconsidered. Thus, the goals of postoperative oxygen
therapy should be to maintain normoxemia and avoid
unnecessary oxygen administration.
To evaluate a patient’s oxygenation status, the SpO2
sensor could be the most appropriate device because it
allows noninvasive and continuous monitoring; more-
over, pulse oximetry has been ubiquitously used in hos-
pitals worldwide. However, although SpO2 monitoring
facilitates hypoxemia detection, it may not help ad-
equately detect hyperoxemia because elevated PaO2 is
not recognized once SpO2 is ≥ 98%. The oxygen reserve
index (ORI), a novel, noninvasive, and continuous vari-
able derived from the SpO2 signal, correlates to elevated
PaO2 and can help detect hyperoxemia [47]. Reportedly,
the use of ORI monitoring to titrate oxygen administra-
tion led to a favorable reduction in the time spent with
hyperoxemia compared with the use of SpO2 alone in
critically ill patients [48]. Such a new monitoring meth-
odology might help improve postoperative oxygen
therapy.
In addition, reports have shown that titration of sup-
plemental oxygen to achieve targeted oxygen saturation
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could reduce oxygen exposure [49, 50]. Recently, two
large RCTs comparing two different oxygen targets in
critically ill patients, including those who had undergone
surgery, have been published. In a single-center RCT in
Italy, including a total of 434 patients, of which 62%
were surgical patients, Girardis et al. compared conser-
vative (target partial pressure of oxygen of 70–100
mmHg or SpO2 of 94–98%) with conventional (target
partial pressure of oxygen of < 150 mmHg or SpO2 of
97–100%) oxygen therapy [51]. Although their findings
showed that conservative oxygen reduced mortality
rates, shock, liver failure, and bacteremia, their study
suffered from serious methodological flaws, including a
single-center design, baseline imbalances, and early ter-
mination after an unplanned interim analysis. Moreover,
ICU-ROX, the largest RCT to date with 1000 patients,
found no difference in outcomes between conservative
(target SpO2 of 90–97%) and conventional (target SpO2
of 90% with no upper limit) oxygen therapy [52]. Over-
all, this study included 295 surgical patients (approxi-
mately 30% of their patients), which limits its
postoperative care comparability. To date, no RCT com-
paring liberal (conventional) and conservative oxygen
therapy has focused on postoperative patients. To our
knowledge, only one study, uncontrolled before-and-
after design, has evaluated the introduction of conserva-
tive oxygen therapy (target SpO2 of 88–92%) for cardiac
surgical patients admitted to the intensive care unit [53].
Accordingly, this study found that conservative oxygen
therapy could promote a significant decrease in hyperox-
emia exposure without increasing the incidence of severe
hypoxemia. Although such findings might support the
feasibility and physiological safety of conservative oxygen
therapy in patients admitted to the intensive care unit
after surgery, currently available studies do not provide
sufficient evidence to guide practice regarding postoper-
ative oxygen therapy. In addition, there might be a dis-
crepancy in oxygen levels defined as liberal oxygen
therapy between the clinical studies comparing two dif-
ferent oxygen targets [51–53] and in the levels reported
to exert physiological harmful effects of supplemental
oxygen and hyperoxemia [18, 21, 22]. So far, no clinical
studies have examined the threshold for the onset of the
association of hyperoxemia or hypoxemia with poor out-
comes in patients postoperatively. Thus, the safe levels
of oxygen and optimal oxygen target in postoperative
patients remain uncertain.
Despite the lack of high-quality evidence, the current
guideline for oxygen use strongly recommends that oxy-
gen saturation be maintained no higher than 96% for
most patients in acute care settings, including postopera-
tive patients [54]. Accordingly, until more evidence is
available, hyperoxemia should not be routinely recom-
mended, while unnecessarily high FIO2 should be
avoided to maintain normoxemia during the postopera-
tive period.
Although previous studies have compared different
levels of FIO2, limited information regarding the number
of patients who developed hypoxemia or hyperoxemia
has been available. Therefore, such an oxygen dose
might be insufficient for some patients but excessive for
others. Future trials should therefore focus on oxygen
titration to achieve target oxygenation levels in order to
avoid both hypoxemia and hyperoxemia.
Conclusions
Postoperative oxygen has been routinely administered to
prevent hypoxemia, with the current guidelines recom-
mending high perioperative oxygen administration to
prevent SSIs. However, available evidence has
highlighted the risks of the current practice and recom-
mendations. In accordance with the “Do No Harm”
principle, routine oxygen supplementation and unneces-
sary hyperoxemia should be avoided during postopera-
tive settings. As such, appropriate monitoring, including
SpO2, and oxygen titration should be performed during
oxygen administration to maintain normoxemia. Future
trials should therefore focus on determining the optimal
oxygen target during postoperative care.
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